Laxido Orange (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polymer that is not absorbed systemically. It stays in the gastrointestinal tract, creating an osmotic gradient that draws water into the lumen. The added fluid softens feces, expands intestinal volume and stimulates peristalsis, facilitating stool passage.

The appropriate dose of Laxido Orange is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of constipation and response to therapy. Patients should follow the individual dosing instructions provided on the prescription label and not exceed the recommended amount.

Safety data for macrogol 3350 in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits and risks before prescribing Laxido Orange to pregnant or nursing women. Use is generally considered only when non‑pharmacologic measures have failed and the expected benefit outweighs possible risks.

To place an order, submit an enquiry on the Laxido Orange product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, macrogol 3350 provides a gentler, osmotic mechanism that softens stool without inducing intestinal cramping. Unlike bulk‑forming agents, it does not rely on fiber fermentation. Its electrolyte‑balanced formulation can be advantageous over plain polyethylene glycol solutions for patients needing additional sodium, potassium or chloride.

Keep the powder in its original, tightly sealed container at ambient temperature, away from direct sunlight and moisture. Protect the package from excessive heat and humidity to maintain product stability. Do not store in the refrigerator or freezer.

Laxido Orange is supplied as a powder that is dissolved in water or another suitable clear fluid according to the instructions on the label. The solution should be mixed thoroughly and consumed promptly after preparation. It is taken orally, usually once daily or as directed by the prescriber.

Although uncommon, serious adverse events can include severe dehydration, significant electrolyte disturbances such as hyponatremia or hypokalemia, and allergic reactions ranging from rash to anaphylaxis. Patients experiencing intense abdominal pain, persistent diarrhea, or signs of an allergic response should seek medical attention immediately.

Laxido Orange is contraindicated in individuals with known or suspected mechanical intestinal obstruction, perforated bowel, or severe inflammatory bowel disease. Patients with severe renal impairment should avoid use unless specifically advised by a physician. It should also be used with caution in the elderly and those with electrolyte disorders.